aTyr Pharma (NASDAQ:ATYR) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
aTyr Pharma (NASDAQ:ATYR – Free Report) had its target price increased by Wells Fargo & Company from $17.00 to $25.00 in a report released on Friday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $35.00 target price on shares of […]
aTyr Pharma (NASDAQ:ATYR – Free Report) had its target price increased by Wells Fargo & Company from $17.00 to $25.00 in a report released on Friday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Separately, HC Wainwright restated a “buy” rating and issued a $35.00 target price on shares of […]
